© 2021 MJH Life Sciences and Consultant Live. All rights reserved.
November 18, 2019
Patients in the propranolol arm recorded a significantly reduced mean office SBP of 130.00 (+/- 13.24) mmHg vs 139.93 (+/- 14.17) mmHg (p = 0.046).
The addition of IPE significantly slowed coronary plaque progression as compared to placebo over 9 months for 4 of the 5 secondary end points.
November 17, 2019
Udenafil positively impacted measures of exercise performance in patients after Fontan, but did not improve peak VO2.
A total of 61.4% of patients in the immediate angiography group and 64.0% of patients in the delayed group were alive 1 year post-cardiac arrest.